Recently, it has also been shown that several antidepressants (such as fluoxetine or imipramine) work through directly binding to TrkB and promoting BDNF signaling, further stressing the importance of pursuing TrkB as a valid target to treat various neurological disorders [29]. The gene discussed is BDNF; the disease is nervous system disorder.